Clinical Trials Browser

Prostatic Neoplasms × Standard of Care × Breast × Clear all

NCT04905082 2025-12-11

HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics

Phase NA Active not recruiting

465 enrolled 11 charts

BreastGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT05754658 2025-10-06

African Cancer Genome: GMD

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT04763915 2025-09-19

IMPACT

Phase NA Active not recruiting

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Neoplastic Syndromes, Hereditary, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT02957981 2023-09-13

GEM

Phase NA Completed

BreastEndocrineGastrointestinalGenitourinary

Breast Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Breast Neoplasms, Male, Multiple Endocrine Neoplasia Type 1

NCT02759783 2019-08-21

CORE

Phase 2/3 Unknown

BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms

NCT00003674 2016-07-13

Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer

Phase 3 Completed

BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma